作者：
Jorge,Mariscal-Harana [1]
;
Peter H,Charlton [1]
;
Samuel,Vennin [1]
;
Jorge,Aramburu [2]
;
Mateusz Cezary,Florkow [3]
;
Arna,van Engelen [1]
;
Torben,Schneider [4]
;
Hubrecht,de Bliek [1]
;
Bram,Ruijsink [5]
;
Israel,Valverde [6]
;
Philipp,Beerbaum [1]
;
Heynric,Grotenhuis [7]
;
Marietta,Charakida [1]
;
Phil,Chowienczyk [8]
;
Spencer J,Sherwin [9]
;
Jordi,Alastruey [10]
作者单位：
Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, King's Health Partners, London, United Kingdom.
[1]
Department of Clinical Pharmacology, King's College London, King's Health Partners, London , United Kingdom.
[2]
TECNUN Escuela de Ingenieros, Universidad de Navarra, Donostia-San Sebastián, Spain.
[3]
Philips Research, Cambridge, United Kingdom.
[4]
Philips Healthcare UK, Philips Centre, Guildford Business Park, Guildford, Surrey, United Kingdom.
[5]
HSDP Clinical Platforms, Philips Healthcare, Eindhoven, The Netherlands.
[6]
Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands.
[7]
Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocío, University of Seville, CIBERCV, CSIC, Seville, Spain.
[8]
Department of Pediatric Cardiology and Intensive Care, Hannover Medical School, Hannover, Germany.
[9]
Department of Pediatric Cardiology, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands.
[10]
Department of Aeronautics, South Kensington Campus, Imperial College London, London, United Kingdom.
[11]
Institute of Personalized Medicine, Sechenov University, Moscow, Russia.
[12]
DOI
10.1152/ajpheart.00241.2020
PMID
33064563
发布时间
2022-03-29
换一批
换一批
